28 February 2014Unilabs and Diagnoplex SA announce the Swiss market launch of Colox®, a non-invasive colon cancer screening test
Unilabs, a leading supplier of clinical laboratory and medical diagnostic imaging services in Europe and Diagnoplex SA, a developer of molecular diagnostics for colorectal cancer announced today the Swiss market launch of Colox®, a non-invasive screening test for colorectal cancer. Colox® is offered as a service by Unilabs’ clinical diagnostic service laboratories in Switzerland. Additional countries within Unilabs’ network of laboratories are planned to follow in 2014.
25 February 2014
InDex Pharmaceuticals today announced the successful closing of a USD 20 million / EUR 15 million new rights issue. NeoMed led the oversubscribed financing round while current shareholders participated with 75% of the invested capital.
6 January 2014
TopiVert Limited, a drug discovery and development company dedicated to improving patient care in inflammatory diseases of the gut and the eye, has announced that it has closed a £17 million financing round.
20 November 2013Sequana Medical appoints Vingmed/ViCare Medical as distributor of the alfapump® system in Scandinavia
Sequana Medical is pleased to announce the appointment of Vingmed and ViCare as distributor for the alfapump system in Norway, Sweden and Denmark.
21 October 2013
NeoMed Innovation IV L.P. has been awarded the prize “Venture Capital Fund of the Year” for its outstanding results over the last 12 months. The award was received at the annual Norwegian Investment Forum, the largest venture capital conference in Norway attended by more than 200 delegates on 15. October 2013. This is the first time a fund exclusively investing in the healthcare industry is receiving this award.